Showing results (741-750 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|August 29, 2012
Methods of solving rapid binding target-mediated drug disposition model for two drugs competing for the same receptorXiaoyu Yan, Yang Chen, Wojciech KrzyzanskiJournal of Pharmacokinetics and Pharmacodynamics|July 7, 2012
A reduction in between subject variability is not mandatory for selecting a new covariateChakradhar V Lagishetty, Pavan Vajjah, Stephen B DuffullJournal of Pharmacokinetics and Pharmacodynamics|July 10, 2012
From in vitro EC₅₀ to in vivo dose-response for antiretrovirals using an HIV disease model. Part II: application to drug developmentJing Fang, Pravin R JadhavJournal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Model-based assessment of erlotinib effect in vitro measured by real-time cell analysisStephan Benay, Christophe Meille, Stefan Kustermann, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 16, 2014
Population pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulatorAndreas Krause, Patrick Brossard, Daniele D'Ambrosio, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 15, 2015
The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experimentsTarjinder Sahota, Meindert Danhof, Oscar Della PasquaJournal of Pharmacokinetics and Pharmacodynamics|February 5, 2015
A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptideElliot Offman, Andrea N EdgintonJournal of Pharmacokinetics and Pharmacodynamics|April 13, 2021
Use of population PK/PD approach to model the thrombin generation assay: assessment in haemophilia A plasma samples spiked by a TFPI antibodyRaphaël Crépin, Claire Morin, Aurélie Montmartin, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 25, 2012
Population pharmacokinetic/pharmacodynamic modelling of the anti-TNF-α polyclonal fragment antibody AZD9773 in patients with severe sepsisJames W T Yates, Shampa Das, Guy Mainwaring, et al.Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichmentJonathan Knights, Shashank RohatagiPageof 107